Assertio’s Phenomenal Turnaround

  • The company has made giant strides in putting its financials in order, getting rid of almost $1B in debt and its net debt has been all but eliminated.
  • We believe more is to come as the company’s all-digital business model is very scalable.
  • There are some risks, the company will have to start paying royalties on its top-selling drug and there might still be some legal risks from their opioid days.
  • Looking for more investing ideas like this one? Get them exclusively at SHU Growth Portfolio. Learn More »

Assertio’s Phenomenal Turnaround (NASDAQ:ASRT)